Medical device giant Medtronic (NYSE: MDT) has been somewhat of a stock market laggard over the past five years, partly due to pandemic-related disruptions. Even beyond this global issue, the ...

Medtronic hasn't been growing its sales at an impressive clip of late. However, one of the company's segments looks increasingly promising. Medtronic has other growth opportunities and is a solid ...

There is even more good news for Medtronic. The company recently earned U.S. clearance for a continuous glucose monitoring (CGM) system called Simplera. It also announced a partnership with Abbott ...

Recommended Reading Friday Q&A: Medtronic’s Ajizian talks connected care ahead of unit spinoff Sam Ajizian has left Medtronic six months after the company reversed its decision to split off its ...

The AID system contains an advanced hybrid closed loop algorithm that automates the delivery of both basal and correction bolus insulin every 5 minutes based on sensor glucose values.

During consultation, some people asked Pharmac to add Medtronic’s brand of CGMs and insulin pumps to the funding proposal. Martin says that Pharmac will not be including the Medtronic devices in ...

Senseonics (NYSE:SENS) announced today that it received FDA clearance for its next-generation Eversense 365 CGM system.

He is a member of a number of advisory boards for companies developing novel diagnostic and therapeutic options for diabetes therapy, including Roche Diagnostics, Sanofi, Abbott, and Medtronic.

Abbott’s latest diabetes device collaboration, the new partnership with Medtronic, was announced less than two weeks ago. Abbott’s FreeStyle Libre devices involve a small sensor applied to the ...

Medtronic has already experienced success with the full market release of its related Simplera Sync sensor internationally, boding well for the U.S. launch of this new CGM. Medtronic will likely ...

New over-the-counter sensors, an Abbott-Medtronic partnership and Roche’s first CGM are among diabetes technology’s top ... while Abbott debuted its Lingo sensor about a week after. Abbott will follow ...